THE DEFINITIVE GUIDE TO HEMGENIX

Quantity of eligible sufferers: CDEC talked about the uncertainty in the quantity of sufferers with moderately significant to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical professionals consulted by CADTH indicated that some sufferers who're labeled as obtaining delicate or moderate illness may have a severe bleedi